Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Asahi Kasei ( (JP:3407) ) has shared an announcement.
The company reported fiscal 2025 third-quarter operating income of ¥173.9 billion, up 6.2% year-on-year, driven by robust pharmaceuticals and steady housing demand, while net income rose 22.7% despite losses tied to structural changes in the materials division. Management raised full-year forecasts for the second consecutive time, now targeting record operating income of ¥259.0 billion and net income of ¥145.0 billion, supported by ongoing strength in priority businesses, a weaker yen, an increased ¥40-per-share dividend, and a ¥40 billion share repurchase underway.
The most recent analyst rating on (JP:3407) stock is a Hold with a Yen1642.00 price target. To see the full list of analyst forecasts on Asahi Kasei stock, see the JP:3407 Stock Forecast page.
More about Asahi Kasei
Asahi Kasei is a diversified Japanese conglomerate spanning healthcare, homes, and materials, with key growth engines in pharmaceuticals, electronics, and domestic housing solutions.
Average Trading Volume: 4,768,828
Technical Sentiment Signal: Buy
Current Market Cap: Yen2038.2B
See more insights into 3407 stock on TipRanks’ Stock Analysis page.